fda approved semaglutide compound Novo asks to prevent compounders from making GLP-1 knockoffs The FDA has strictly clarified

Gopal Grandhige, M.D., and the clinical team take a fundamentally different approach

The focus on b12 specifically appears to be marketing rather than science

In a report published in November, 2023, based on data collected between 2015 and 2022, an estimated 30% of Canadian adults were classified as obese based on BMI measures (i.e., BMI greater than 30)

Calculator Use the Peptide Reconstitution Calculator on PepPal for any custom vial size or BAC water volume across both compounds in this stack

History of Type 2 Diabetes or Obesity You may also be eligible for GLP-1 treatment if you have a medical history of type 2 diabetes, heart disease, or both